Annette Bruls

CIK: 0002032351

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (16.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)3 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Edwards Lifesciences Corp

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

EW
Edwards Lifesciences Corp
Aug 28, 2026
Sale(S)
Direct
2.6K shares at avg. $89.98$238K
EW
Edwards Lifesciences Corp
Jul 11, 2026
Tax Payment(F)
Direct
109 shares at avg. $92.21$10K
EW
Edwards Lifesciences Corp
May 8, 2026
Tax Payment(F)
Direct
84 shares at avg. $82.76$7K
EW
Edwards Lifesciences Corp
May 7, 2026
Award(A)
Direct
6.7K shares-
EW
Edwards Lifesciences Corp
Jul 11, 2025
Tax Payment(F)
Direct
109 shares at avg. $78.80$9K
EW
Edwards Lifesciences Corp
May 8, 2025
Award(A)
Direct
6.2K shares-

		Type	Shares	Price		Ownership
Aug 28, 2026	EW Edwards Lifesciences Corp	Sale(S)	2,644	$89.98	$237,907	Direct
Jul 11, 2026	EW Edwards Lifesciences Corp	Tax Payment(F)	109	$92.21	$10,051	Direct
May 8, 2026	EW Edwards Lifesciences Corp	Tax Payment(F)	84	$82.76	$6,952	Direct
May 7, 2026	EW Edwards Lifesciences Corp	Award(A)	6,650	-	$0	Direct
Jul 11, 2025	EW Edwards Lifesciences Corp	Tax Payment(F)	109	$78.80	$8,589	Direct
May 8, 2025	EW Edwards Lifesciences Corp	Award(A)	6,200	-	-	Direct

1-6 of 6 transactions

About Bruls Annette

Bruls Annette (SEC CIK 0002032351) files insider reports with the SEC as CVP, EMEACLA of Edwards Lifesciences Corp (EW).

Signal8 holds 5 ownership filings by Bruls Annette, all Form 4s, filed between May 9, 2025 and Aug 28, 2026. Those filings report 6 transactions, from May 8, 2025 to Aug 28, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Bruls Annette's filings is in IRVINE, CA.

Recent filings by Bruls Annette

Aug 28, 2026: Open-market sale of EW shares (Form 4, code S).
Jul 11, 2026: Tax withholding of EW shares (Form 4, code F).
May 8, 2026: Tax withholding of EW shares (Form 4, code F).
May 7, 2026: Grant or award of EW shares (Form 4, code A).
Jul 11, 2025: Tax withholding of EW shares (Form 4, code F).

Other insiders filing for Edwards Lifesciences Corp (EW)

Lippis Daniel J., CVP, TAVR
Markowitz Wayne, CVP, JAPAC
Dahl Andrew M., SVP, Corporate Controller
Chopra Daveen, CVP, TMTT, Surgical & IHFM
Zovighian Bernard J, CEO
Mistras Theodora, CVP, Chief Financial Officer

How to read Form 4 transaction codes